- Home
- LYTS vs SVRA Comparison
LYTS vs SVRA Comparison
Compare LYTS & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYTS
- SVRA
- Stock Information
- Founded
- LYTS 1976
- SVRA 2007
- Country
- LYTS United States
- SVRA United States
- Employees
- LYTS N/A
- SVRA N/A
- Industry
- LYTS Building Products
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- LYTS Consumer Discretionary
- SVRA Health Care
- Exchange
- LYTS Nasdaq
- SVRA Nasdaq
- Market Cap
- LYTS 518.5M
- SVRA 528.3M
- IPO Year
- LYTS N/A
- SVRA N/A
- Fundamental
- Price
- LYTS $16.08
- SVRA $2.38
- Analyst Decision
- LYTS Strong Buy
- SVRA Buy
- Analyst Count
- LYTS 2
- SVRA 7
- Target Price
- LYTS $26.00
- SVRA $7.57
- AVG Volume (30 Days)
- LYTS 104.2K
- SVRA 2.6M
- Earning Date
- LYTS 04-24-2025
- SVRA 05-13-2025
- Dividend Yield
- LYTS 1.23%
- SVRA N/A
- EPS Growth
- LYTS N/A
- SVRA N/A
- EPS
- LYTS 0.72
- SVRA N/A
- Revenue
- LYTS $547,316,000.00
- SVRA N/A
- Revenue This Year
- LYTS $21.02
- SVRA N/A
- Revenue Next Year
- LYTS $7.32
- SVRA N/A
- P/E Ratio
- LYTS $22.67
- SVRA N/A
- Revenue Growth
- LYTS 17.89
- SVRA N/A
- 52 Week Low
- LYTS $13.63
- SVRA $1.89
- 52 Week High
- LYTS $25.50
- SVRA $5.11
- Technical
- Relative Strength Index (RSI)
- LYTS 49.83
- SVRA 40.34
- Support Level
- LYTS $15.92
- SVRA $1.89
- Resistance Level
- LYTS $16.47
- SVRA $2.55
- Average True Range (ATR)
- LYTS 0.36
- SVRA 0.20
- MACD
- LYTS 0.02
- SVRA -0.04
- Stochastic Oscillator
- LYTS 59.69
- SVRA 37.40
About LYTS LSI Industries Inc.
LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Lighting segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays and custom display elements.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.